QuidelOrtho Corp- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 QuidelOrtho Corp 公司

QuidelOrtho Corporation 从事体外诊断、开发和制造智能解决方案。该公司通过直销团队和分销商网络将其产品直接销售给最终用户，供医生办公室、医院、临床实验室、参考实验室、紧急护理诊所、大学、零售诊所、药房、健康筛查中心、其他即时诊断 (POC) 场所、血库和捐献中心的专业使用，以及供个人、非专业、非处方 (OTC) 使用。该公司以各种品牌提供诊断测试解决方案，包括 AdenoPlus、BIOVUE、FreshCells、InflammaDry、Lyra、MeterPro、MicroVue、Ortho、Ortho Clinical Diagnostics、Ortho Connect、Ortho Plus、Ortho Vision、QuickVue、Quidel、QuidelOrtho、QVue、Savanna、Sofia、Solana、Thyretain、Triage、Virena、Vitros 等。它为 130 多个国家和地区的客户提供支持。

公司简介

公司代码QDEL

公司名称QuidelOrtho Corp

上市日期Feb 01, 1991

成立日期2021

CEOMr. Brian J. Blaser

员工数量6600

证券类型Ordinary Share

年结日Feb 01

公司地址9975 Summers Ridge Road

城市SAN DIEGO

上市交易所NASDAQ Global Select Consolidated

国家United States of America

邮编92121

电话18585521100

网址https://www.quidelortho.com/

公司代码QDEL

上市日期Feb 01, 1991

成立日期2021

公司高管

名称

名称/职务

职务

持股

持股变动

Dr. Kenneth F. Buechler, Ph.D.

Independent Chairman of the Board

89.24K

--

Dr. Matthew W. Strobeck, Ph.D.

Independent Director

67.62K

--

Ms. Michelle A. Hodges, J.D.

Senior Vice President, Corporate Secretary, Chief Legal Officer

23.16K

+9.93%

Mr. Joseph M. Busky

Chief Financial Officer

19.17K

+20.97%

Mr. Edward L. (Ed) Michael

Independent Director

15.70K

--

Ms. Ann D. Rhoads

Independent Director

8.13K

--

Ms. Evelyn S. Dilsaver

Independent Director

--

Mr. Lee Bowman

Chief Human Resources Officer

--

Dr. Kenneth Jon (Ken) Widder, M.D.

Independent Director

--

Mr. Joseph D. Wilkins, Jr.

Independent Director

--

名称

名称/职务

职务

持股

持股变动

Dr. Kenneth F. Buechler, Ph.D.

Independent Chairman of the Board

89.24K

--

Dr. Matthew W. Strobeck, Ph.D.

Independent Director

67.62K

--

Ms. Michelle A. Hodges, J.D.

Senior Vice President, Corporate Secretary, Chief Legal Officer

23.16K

+9.93%

Mr. Joseph M. Busky

Chief Financial Officer

19.17K

+20.97%

Mr. Edward L. (Ed) Michael

Independent Director

15.70K

--

Ms. Ann D. Rhoads

Independent Director

8.13K

--

收入明细

单位: USD更新时间: 4月6日周日

FY2024

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Labs

1.43B

51.27%

Point-of-Care

694.10M

24.94%

Immunohematology

522.60M

18.78%

Donor Screening

115.50M

4.15%

Molecular Diagnostic Solutions

24.00M

0.86%

地区USD

名称

营收

占比

United States

1.57B

56.37%

Foreign

1.21B

43.63%

业务

地区

业务USD

名称

营收

占比

Labs

1.43B

51.27%

Point-of-Care

694.10M

24.94%

Immunohematology

522.60M

18.78%

Donor Screening

115.50M

4.15%

Molecular Diagnostic Solutions

24.00M

0.86%

股东统计

更新时间: 2月23日周日

持股股东

股东类型

持股股东

股东统计

占比

T. Rowe Price Investment Management, Inc.

16.66%

BlackRock Institutional Trust Company, N.A.

11.54%

The Vanguard Group, Inc.

10.08%

Rubric Capital Management LP

8.23%

Invesco Advisers, Inc.

4.78%

Other

48.71%

持股股东

股东统计

占比

T. Rowe Price Investment Management, Inc.

16.66%

BlackRock Institutional Trust Company, N.A.

11.54%

The Vanguard Group, Inc.

10.08%

Rubric Capital Management LP

8.23%

Invesco Advisers, Inc.

4.78%

Other

48.71%

股东类型

股东统计

占比

Investment Advisor

46.41%

Investment Advisor/Hedge Fund

38.01%

Hedge Fund

20.96%

Research Firm

1.63%

Sovereign Wealth Fund

1.20%

Pension Fund

1.17%

Individual Investor

0.78%

Bank and Trust

0.59%

Family Office

0.15%

机构持股

更新时间: 3月4日周二

报告期

机构数

持股数

持股占比

持股变动

2025Q1

709

74.95M

111.12%

-12.34M

2024Q4

747

75.07M

111.30%

-13.02M

2024Q3

744

73.58M

109.44%

-4.02M

2024Q2

767

70.18M

104.79%

-7.57M

2024Q1

799

67.05M

100.24%

-5.28M

2023Q4

828

68.21M

102.09%

-2.95M

2023Q3

842

70.19M

105.17%

-4.01M

2023Q2

860

68.99M

103.61%

-6.94M

2023Q1

894

68.68M

103.29%

-6.80M

2022Q4

939

69.19M

108.75%

-5.89M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

T. Rowe Price Investment Management, Inc.

11.24M

16.66%

+1.84M

+19.59%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

7.79M

11.54%

+1.09M

+16.28%

Dec 31, 2024

The Vanguard Group, Inc.

6.80M

10.08%

-21.19K

-0.31%

Dec 31, 2024

Rubric Capital Management LP

5.55M

8.23%

+1.35M

+32.14%

Dec 31, 2024

Invesco Advisers, Inc.

3.23M

4.78%

+1.44M

+81.05%

Dec 31, 2024

State Street Global Advisors (US)

2.27M

3.37%

+366.13K

+19.19%

Dec 31, 2024

ArrowMark Colorado Holdings, LLC

1.98M

2.93%

+100.52K

+5.35%

Dec 31, 2024

D. E. Shaw & Co., L.P.

1.73M

2.56%

+50.77K

+3.03%

Dec 31, 2024

Fidelity Management & Research Company LLC

1.25M

1.85%

+30.51K

+2.50%

Dec 31, 2024

Dimensional Fund Advisors, L.P.

1.22M

1.8%

+107.78K

+9.72%

Dec 31, 2024

持股ETF

更新时间: 4月6日周日

机构名称

占比

Invesco S&P SmallCap Health Care ETF

1.57%

SPDR S&P Health Care Equipment ETF

1.45%

First Trust Nasdaq Lux Digi Health Solutions ETF

0.89%

Ballast Small/Mid Cap ETF

0.48%

WisdomTree US SmallCap Quality Growth Fund

0.39%

SPDR S&P 600 Small Cap Value ETF

0.34%

iShares S&P Small-Cap 600 Value ETF

0.33%

VictoryShares US Small Mid Cap Value Momentum ETF

0.28%

Avantis US Small Cap Value ETF

0.27%

JPMorgan Fundamental Data Science Mid Core ETF

0.26%

Invesco S&P SmallCap Health Care ETF

占比1.57%

SPDR S&P Health Care Equipment ETF

占比1.45%

First Trust Nasdaq Lux Digi Health Solutions ETF

占比0.89%

Ballast Small/Mid Cap ETF

占比0.48%

WisdomTree US SmallCap Quality Growth Fund

占比0.39%

SPDR S&P 600 Small Cap Value ETF

占比0.34%

iShares S&P Small-Cap 600 Value ETF

占比0.33%

VictoryShares US Small Mid Cap Value Momentum ETF

占比0.28%

Avantis US Small Cap Value ETF

占比0.27%

JPMorgan Fundamental Data Science Mid Core ETF

占比0.26%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

QuidelOrtho Corp

28.580USD

QuidelOrtho Corp

28.580

概览

公司